IRLAB Therapeutics Beheer
Beheer criteriumcontroles 1/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Kristina Torfgard
Algemeen directeur
n/a
Totale compensatie
Percentage CEO-salaris | n/a |
Dienstverband CEO | less than a year |
Eigendom CEO | n/a |
Management gemiddelde ambtstermijn | 11.8yrs |
Gemiddelde ambtstermijn bestuur | 2.5yrs |
Recente managementupdates
Recent updates
Is IRLAB Therapeutics (STO:IRLAB A) Using Debt Sensibly?
Oct 30IRLAB Therapeutics (STO:IRLAB A) Has Debt But No Earnings; Should You Worry?
Jun 06Here's Why We're Watching IRLAB Therapeutics' (STO:IRLAB A) Cash Burn Situation
Jan 04Here's Why IRLAB Therapeutics (STO:IRLAB A) Must Use Its Cash Wisely
Sep 21We Think IRLAB Therapeutics (STO:IRLAB A) Needs To Drive Business Growth Carefully
Mar 18IRLAB Therapeutics (STO:IRLAB A) Is In A Good Position To Deliver On Growth Plans
Dec 01We Like IRLAB Therapeutics' (STO:IRLAB A) Earnings For More Than Just Statutory Profit
May 19We're Interested To See How IRLAB Therapeutics (STO:IRLAB A) Uses Its Cash Hoard To Grow
Sep 11We're Interested To See How IRLAB Therapeutics (STO:IRLAB A) Uses Its Cash Hoard To Grow
Apr 30What Is The Ownership Structure Like For IRLAB Therapeutics AB (publ) (STO:IRLAB A)?
Mar 19We Think IRLAB Therapeutics (STO:IRLAB A) Can Afford To Drive Business Growth
Jan 25Our View On IRLAB Therapeutics' (STO:IRLAB A) CEO Pay
Dec 21What Is The Ownership Structure Like For IRLAB Therapeutics AB (publ) (STO:IRLAB A)?
Nov 25CEO
Kristina Torfgard (61 yo)
less than a year
Tenure
Dr. Kristina Torfgard, Ph.D. is Chief Executive Officer of IRLAB Therapeutics AB (publ) from August 1, 2024. Dr. Torfgard served as Vice President & Global Project Head at Albireo AB. Dr. Torfgard served a...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Chief Executive Officer | less than a year | geen gegevens | geen gegevens | |
Chief Financial Officer | 7.8yrs | geen gegevens | 0.46% SEK 3.4m | |
Chief Scientific Officer | 11.8yrs | geen gegevens | 1.46% SEK 10.7m | |
Chief Information Officer and Director of Computational Chemistry & Biology | 11.8yrs | geen gegevens | 0.50% SEK 3.7m | |
Global IR & Communications | no data | geen gegevens | geen gegevens | |
Head of Finance & Human Resource and Director of Accounting & Human Resources | 11.8yrs | geen gegevens | 0.70% SEK 5.1m | |
Executive VP and Head of R&D | no data | SEK 1.70m | 1.44% SEK 10.5m | |
Chief Medical Officer | 11.8yrs | SEK 5.00k | 1.22% SEK 8.9m |
11.8yrs
Gemiddelde duur
62yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van IRLAB A is doorgewinterd en ervaren (gemiddelde ambtstermijn van 11.8 jaar).
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Independent Director | 8.8yrs | SEK 256.25k | 0.081% SEK 590.8k | |
Independent Chairman of the Board | 6.8yrs | SEK 400.00k | 0.027% SEK 197.4k | |
Director | 1.4yrs | SEK 147.50k | geen gegevens | |
Independent Director | 1.4yrs | SEK 160.00k | geen gegevens | |
Director | 7.8yrs | SEK 3.10m | 0.012% SEK 84.6k | |
Independent Director | 2.5yrs | SEK 264.17k | 0.015% SEK 112.8k | |
Director | 1.4yrs | SEK 175.00k | 8.71% SEK 63.7m |
2.5yrs
Gemiddelde duur
62yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van IRLAB A wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 2.5 jaar), wat duidt op een nieuw bestuur.